ChartMill · Oct 22, 2026
Top US Stock Gainers and Losers for the Oct. 22, 2026 Session
STAK Inc-A led US stock gainers with a 63.5% jump and POMDOCTOR LTD - ADR led losers with a 39.83% drop in the Oct. 22, 2026 session.
PF
NASDAQ · PFSA
Profusa, Inc. Common Stock
Healthcare · Medical - Equipment & Services
$0.62
Down-$0.00 (-0.21%)
Updated Nov 5, 2026, 2:52 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.48M
- P/E ratio
- -0.14
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $28.32
- Volume
- 219.03K
- Avg. volume
- 12.57M
Price performance · PFSA
PFSA price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
PFSA closed at $0.62 after 21 trading sessions, down 58.86% for the selected period.
- Last close
- $0.62
- Period change
- -58.86%
- Period low
- $0.62
- Period high
- $1.50
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $0.646 | $0.6495 | $0.5733 | $0.6171 | 219.03K |
| Nov 3, 2026 | $0.625 | $0.6698 | $0.6085 | $0.6184 | 282.55K |
| Nov 2, 2026 | $0.732 | $0.7446 | $0.5984 | $0.651 | 191.6K |
| Oct 30, 2026 | $0.775 | $0.775 | $0.6859 | $0.7001 | 162.43K |
| Oct 29, 2026 | $0.75 | $0.78 | $0.71 | $0.7709 | 191.08K |
| Oct 28, 2026 | $0.7517 | $0.7792 | $0.70 | $0.7656 | 262.16K |
| Oct 27, 2026 | $0.7775 | $0.7903 | $0.7203 | $0.7795 | 296.73K |
| Oct 26, 2026 | $0.77 | $0.8197 | $0.7371 | $0.7797 | 399.47K |
| Oct 23, 2026 | $1.06 | $1.08 | $0.8206 | $0.8391 | 1.18M |
| Oct 22, 2026 | $1.03 | $1.35 | $0.90 | $1.02 | 45.02M |
| Oct 21, 2026 | $0.8638 | $0.8638 | $0.70 | $0.8492 | 226.69K |
| Oct 20, 2026 | $0.8885 | $0.9018 | $0.8249 | $0.885 | 145.73K |
| Oct 19, 2026 | $0.9323 | $0.9399 | $0.88 | $0.9002 | 114.61K |
| Oct 16, 2026 | $1.02 | $1.0267 | $0.931 | $0.9311 | 143.01K |
| Oct 15, 2026 | $1.06 | $1.08 | $0.91 | $1.07 | 3.47M |
| Oct 14, 2026 | $1.25 | $1.45 | $1.18 | $1.28 | 629.39K |
| Oct 13, 2026 | $1.28 | $1.31 | $1.23 | $1.28 | 99.09K |
| Oct 12, 2026 | $1.36 | $1.4032 | $1.25 | $1.30 | 265.96K |
| Oct 9, 2026 | $1.42 | $1.53 | $1.40 | $1.42 | 235.56K |
| Oct 8, 2026 | $1.53 | $1.65 | $1.45 | $1.49 | 818.96K |
| Oct 7, 2026 | $1.62 | $1.68 | $1.42 | $1.50 | 424.23K |
Latest PFSA news
The latest Smart Investors Daily articles mentioning PFSA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
PFSA research
Overview
Company profile and research snapshot.
Company profile
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
ChartMill · Oct 22, 2026
Top Gainers and Losers in Today's US Session
Today's US session saw top gainers rise as much as 111.0% and top losers fall as much as 36.86%, with SHFS leading gainers and AVTX leading losers.
Yahoo · Oct 15, 2026
Profusa Receives ISO 13485:2016 Certificate from GMED
Providing a Foundational Quality Management System (QMS) for Commercialization Certificate issued by GMED, an EU MDR notified body, following the positive certification decision previously announcedISO 13485 certification supports ongoing MDR conformity assessment activities for the Lumee Oxygen Platform and represents an important milestone toward MDR certification and CE marking. BERKELEY, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) ("Profusa" or the "Company"), a di
Benzinga · Oct 15, 2026
Profusa Secures Its ISO 13485:2016 Certificate From EU MDR Notified Body, GMED, Covering Lumee Oxygen Platform
Providing a Foundational Quality Management System (QMS) for CommercializationCertificate issued by GMED, an EU MDR notified body, following the positive certification decision previously announcedISO 13485
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
